Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Advanced NanoTherapies raised over $31M in Series B funding led by S3 Ventures to scale manufacturing and advance clinical trials.
PRIVATEJun 02, 2026•2 months ago
Amount Raised
$31 Million
Round Type
Series B
Los GatosManufacturingBiotechnologyHealth CareScience And EngineeringInvestors
Undisclosed Strategic InvestorT45 FundS3 Ventures
Description
Advanced NanoTherapies, a developer of a nanoparticle-coated dual-drug balloon platform for vascular treatment, raised over $31M in Series B funding. The round was co-led by an undisclosed strategic investor and S3 Ventures, with participation from T45 Fund and others. The company plans to use the funds for manufacturing capabilities and clinical trials. They have also secured FDA breakthrough designation for their lead program.
Related People
Suggested for you
1 contactVerified contacts5 people are listed at Advanced NanoTherapies — we don't have their email yet.
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech